Portal de Periódicos da CAPES

Effect of Structural Modification of Enol−Carboxamide-Type Nonsteroidal Antiinflammatory Drugs on COX-2/COX-1 Selectivity

1997; American Chemical Society; Volume: 40; Issue: 6 Linguagem: Inglês

10.1021/jm9607010

1520-4804

Edward S. Lazer, Clara K. Miao, Charles L. Cywin, Ronald Sorcek, Hin-Chor Wong, Zhaoxing Meng, Ian Potocki, MaryAnn Hoermann, Roger J. Snow, Matt A. Tschantz, Terence A. Kelly, Daniel W. McNeil, Simon J. Coutts, Laurie Churchill, Anne G. Graham, Eva David, Peter M. Grob, Wolfhard Engel, Hans Meier, G. Trummlitz,

Phenothiazines and Benzothiazines Synthesis and Activities

Meloxicam (5), an NSAID in the enol−carboxamide class, was developed on the basis of its antiinflammatory activity and relative safety in animal models. In subsequent screening in microsomal assays using human COX-1 and COX-2, we discovered that it possessed a selectivity profile for COX-2 superior to piroxicam and other marketed NSAIDs. We therefore embarked on a study of enol−carboxamide type compounds to determine if COX-2 selectivity and potency could be dramatically improved by structural modification. Substitution at the 6- and 7-positions of the 4-oxo-1,2-benzothiazine-3-carboxamide, alteration of the N-methyl substituent, and amide modification were all examined. In addition we explored several related systems including the isomeric 3-oxo-1,2-benzothiazine-4-carboxamides, thienothiazines, indolothiazines, benzothienothiazines, naphthothiazines, and 1,3- and 1,4-dioxoisoquinolines. While a few examples were found with greater potency in the COX-2 assay, no compound tested had a better COX-2/COX-1 selectivity profile than that of 5.